Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 50 | 271↑440.8% | 386↑42.5% |
| Gross Profit | 0 | 0 | 45 | 245↑445.4% | 352↑44.1% |
| Operating Income | -99 | -125↓25.8% | -180↓44.2% | -232↓28.9% | -281↓21.0% |
| Net Income | -103 | -130↓26.7% | -187↓43.5% | -239↓27.8% | -287↓20.1% |
| EBITDA | -100 | -125↓24.2% | -175↓40.7% | -225↓28.3% | -273↓21.2% |
| EPS Diluted | -2.83 | -3.47↓22.6% | -4.60↓32.6% | -5.27↓14.6% | -5.99↓13.7% |